IHS Chemical Week

World News and Views :: Projects

Carbogen Amcis to Open High Potency API Unit in India

9:26 AM MDT | April 21, 2008 | Deepti Ramesh

Research and active pharma ingredient (API) manufacturer Carbogen Amcis AG (Bubendorf, Switzerland) says that its Indian subsidiary Carbogen Amcis India Ltd. (Ahmedabad, India) will open a facility for high potency APIs at Bavla, India by the first quarter of 2009. The Bavla facility, which is at the site of parent firm Dishman Pharmaceuticals & Chemicals Ltd., will cater to both cytotoxic and non-cytotoxic highly active substances in dedicated areas. Construction is under way, says Carbogen Amcis, which is designing the facility and plans to operate it...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa